Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

CANC

Tema Oncology ETF

May 03 • 09:33AM ET

27.82

Dollar change +0.44
Percentage change 1.61	%

Financial • Exchange Traded Fund • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Category	Global or ExUS Equities - Industry Sector	Asset Type	Equities (Stocks)	Tags	Global	Return% 1Y	-	Shs Outstand		Perf Week	7.25%
Sponsor	Tema	ETF Type		Tags	equity	Return% 3Y	-	Total Holdings	48	Perf Month	3.15%
Fund Family		Bond Type		Tags	healthcare	Return% 5Y	-	AUM	18.61M	Perf Quarter	5.22%
Index	-	Average Maturity		Tags	-	Return% 10Y		NAV%		Perf Half Y	29.65%
Index Weighting		Commodity Type		Tags	-	Return% SI		NAV/sh		Perf Year	-
Active/Passive		Quant Type		Tags	-	Flows% 1M	0.00%	52W Range	21.46 - 29.16	Perf YTD	5.39%
Dividend TTM	0.13 (0.48%)	ESG Type		Tags	-	Flows% 3M	1.53%	52W High	-4.60%	Beta	-
Dividend Ex-Date	Dec 13, 2023	Dividend Type		Sector/Theme		Flows% YTD	2.98%	52W Low	29.65%	ATR (14)	0.35
Expense	0.75%	Structure Type		Region		Flows% 1Y		RSI (14)	63.93	Volatility	0.82% 0.40%
Option/Short	No / Yes	Growth/Value		Dev/Emerg		Flows% 3Y		Rel Volume	0.01	Prev Close	27.38
Inverse/Leveraged		Market Cap		Currency		Flows% 5Y		Avg Volume	0.63K	Price	27.82
SMA20	5.86%	SMA50	2.19%	SMA200	9.44%	Trades		Volume	4	Change	1.61%

Tema Oncology ETF seeks to provide long-term growth. Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.

open in yahoo | open in marketwatch | open in google

CANC

Tema Oncology ETF

Upgrade your FINVIZ experience